AKR1B10 and leprosy: Of the leprosy lesions and healthy skin samples from our previous study, which reported transcriptional upregulation of AKR1B10 in R2 samples, all healthy controls (n = 9), leprosy lesion samples from the R&J spectrum (10 TT, BT, BB, and BL samples; 4 LL samples), and R1 samples [n = 14; Figures 1E–S; (23)] were negative.